Barrett’s esophagus is a pathology in which the complex squamous epithelium of the lower esophagus undergoes chemotaxis into a single layer of columnar epithelium, covering the original esophageal epithelium, and the lesion may be enteric. Those who already have special intestinal epithelial chemotaxis are considered to have precancerous lesions. The disease was first discovered and reported by Barrett in the United Kingdom, hence the name, and is called Barrett’s esophagus in Chinese.
It is now believed that there may be a close relationship between Barrett and gastroesophageal reflux disease (GERD), but the exact pathogenesis is not clear. It is usually found in middle-aged and elderly men, most of them are asymptomatic, and a few of them have symptoms such as heartburn and chest pain. Gastroscopy can be detected. Treatment is mainly focused on controlling reflux symptoms, preventing complications and avoiding malignancy. Treatment includes medication, endoscopic follow-up, microscopic minimally invasive stripping or surgical resection.
If the above symptoms are already present or Barrett’s esophagus has been diagnosed, treatment should be carried out under the guidance of a physician.